Fundraising Fox

Hydrocision

North Billerica, US · Delaware corporation · 2 known investors

HydroCision develops minimally invasive surgical instruments using proprietary FluidJet technology to selectively remove soft tissue in a precise manner. The company serves surgeons and hospitals across multiple medical specialties seeking improved surgical outcomes.

Founders & leadership

PK
PAUL KOWALSKIExecutive
RA
RICHARD A. LYTLE, IIIExecutive
TD
THOMAS D. ABERTExecutive
PV
PATRICIA VANBLARCOMExecutive
RL
Rick LytlePresident & Chief Executive Officer

Board

LZ
LONG ZHANBoard director
BG
BRYAN GRULKEBoard director
ME
MARC E. GOLDBERGBoard director
YX
YU XIAOTONGBoard director
DW
DOUG WALLBoard director
TW
TERRY WALLBoard director
HW
Howard W. DonnellyChairman of the Board

Investors · 2

Reported raises · per SEC filings

Form D private placements

$5.5M disclosed across 2 rounds · 2017–2024

$2.5MraisedApr 2025 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • PAUL KOWALSKIExecutive Officer
  • DOUG WALLDirector
  • TERRY WALLDirector
  • LONG ZHANDirector
  • BRYAN GRULKEDirector
  • HOWARD W. DONNELLYDirector
  • RICHARD A. LYTLE, IIIExecutive Officer, Director
  • THOMAS D. ABERTExecutive Officer
  • MARC E. GOLDBERGDirector
Offering amount
$3.9M
Amount sold
$2.5M
Proceeds to insiders
$100.1K
First sale
Nov 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$3MraisedMar 2017 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • DOUG WALLDirector
  • TERRY WALLDirector
  • YU XIAOTONGDirector
  • PATRICIA VANBLARCOMExecutive Officer
  • PAUL KOWALSKIExecutive Officer
  • HOWARD DONNELLYDirector
  • MARC GOLDBERGDirector
Offering amount
$4M
Amount sold
$3M
First sale
Mar 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Companies competing with Hydrocision for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2023$300K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Frequently asked questions

What does Hydrocision do?
HydroCision develops minimally invasive surgical instruments using proprietary FluidJet technology to selectively remove soft tissue in a precise manner. The company serves surgeons and hospitals across multiple medical specialties seeking improved surgical outcomes.
Who are Hydrocision's investors?
Hydrocision's investors include Newbury Ventures, Oxford Bioscience Partners.
How much funding has Hydrocision raised?
Hydrocision has disclosed $5.5M raised across 2 rounds.
Where is Hydrocision headquartered?
Hydrocision is headquartered in North Billerica, US.